Cargando…

Pharmacokinetic interaction between rhynchopylline and pellodendrine via CYP450 enzymes and P-gp

CONTEXT: Rhynchopylline and pellodendrine are major extractions of commonly used Chinese medicine in gynaecology. The interaction between these two compounds could affect treatment efficiency and even result in toxicity during their co-administration in gynaecological prescription. OBJECTIVE: The ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Qingzhen, Cheng, Yongheng, Zhou, Cui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583760/ https://www.ncbi.nlm.nih.gov/pubmed/34757861 http://dx.doi.org/10.1080/13880209.2021.1999988

Ejemplares similares

Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes
por: Raunio, Hannu, et al.
Publicado: (2015)

Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin
por: Chen, Chia-Hao, et al.
Publicado: (2012)

Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
por: Wang, Hao, et al.
Publicado: (2020)

No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P‐glycoprotein (P‐gp) drug transporter
por: Aubets, Jordi, et al.
Publicado: (2019)

Evaluating the effect of type 2 diabetes mellitus on CYP450 enzymes and P-gp activities, before and after glycemic control: A protocol for a case–control pharmacokinetic study
por: Neyshaburinezhad, Navid, et al.
Publicado: (2020)

Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy
por: Preissner, Sarah C., et al.
Publicado: (2013)

SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions
por: Preissner, Saskia, et al.
Publicado: (2010)

Compound Shuganjieyu Capsule on CYP450 Enzyme Activity
por: Tang, Yunqiu, et al.
Publicado: (2022)

Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats
por: Shi, Yong, et al.
Publicado: (2021)

Pharmacokinetics of asciminib in the presence of CYP3A or P‐gp inhibitors, CYP3A inducers, and acid‐reducing agents
por: Hoch, Matthias, et al.
Publicado: (2022)

Functional Characterization of CYP716 Family P450 Enzymes in Triterpenoid Biosynthesis in Tomato
por: Yasumoto, Shuhei, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes
por: Jamwal, Rohitash, et al.
Publicado: (2020)

Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein
por: Cho, Hyun-Jong, et al.
Publicado: (2015)

Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates
por: Otsuka, Yukio, et al.
Publicado: (2023)

6. Dose Adjustments Based on Pharmacogenetics of CYP450 Enzymes
por: van Schaik, Ron H.N.
Publicado: (2008)

The cytochrome P450 (CYP) superfamily in cnidarians
por: Pankov, Kirill V., et al.
Publicado: (2021)

Influence of Selected Carbon Nanostructures on the CYP2C9 Enzyme of the P450 Cytochrome
por: Sekretarska, Justyna, et al.
Publicado: (2019)

Physiologically‐based pharmacokinetic modeling of quinidine to establish a CYP3A4, P‐gp, and CYP2D6 drug–drug–gene interaction network
por: Feick, Denise, et al.
Publicado: (2023)

Testing the Pharmacokinetic Interactions of 24 Colonic Flavonoid Metabolites with Human Serum Albumin and Cytochrome P450 Enzymes
por: Mohos, Violetta, et al.
Publicado: (2020)

CYP450 Enzyme-Mediated Metabolism of TCAS and Its Inhibitory and Induced Effects on Metabolized Enzymes in Vitro
por: Shen, Guolin, et al.
Publicado: (2015)

Assessment of the potential of the MET inhibitor tepotinib to affect the pharmacokinetics of CYP3A4 and P-gp substrates
por: Yalkinoglu, Özkan, et al.
Publicado: (2023)

Cytochrome P450 and P-gp Mediated Herb-Drug Interactions and Molecular Docking Studies of Garcinol
por: Bolla, Lavanya, et al.
Publicado: (2021)

Bioactivation of Aromatic Amines by Human CYP2W1, An Orphan Cytochrome P450 Enzyme
por: Eun, Chang-Yong, et al.
Publicado: (2010)

Single-Walled Carbon Nanotubes Inhibit the Cytochrome P450 Enzyme, CYP3A4
por: El-Sayed, Ramy, et al.
Publicado: (2016)

Current High-Throughput Approaches of Screening Modulatory Effects of Xenobiotics on Cytochrome P450 (CYP) Enzymes
por: Ung, Yee Tze, et al.
Publicado: (2018)

Influences of Corydalis decumbens on the Activities of CYP450 Enzymes in Rats with a Cocktail Approach
por: Cheng, Chen, et al.
Publicado: (2019)

Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study
por: Solan, Megan E., et al.
Publicado: (2023)

Phylogenetic analysis of the cytochrome P450 (CYP450) nucleotide sequences of the horse and predicted CYP450s of the white rhinoceros (Ceratotherium simum) and other mammalian species
por: Leiberich, Marion, et al.
Publicado: (2018)

Effect of enzalutamide on PK of P‐gp and BCRP substrates in cancer patients: CYP450 induction may not always predict overall effect on transporters
por: Poondru, Srinivasu, et al.
Publicado: (2022)

Inhibitory mechanism of vortioxetine on CYP450 enzymes in human and rat liver microsomes
por: Zhan, Yunyun, et al.
Publicado: (2023)

Function and regulation of a steroidogenic CYP450 enzyme in the mitochondrion of Toxoplasma gondii
por: Asady, Beejan, et al.
Publicado: (2023)

Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites
por: F. Martins, Margarida L., et al.
Publicado: (2022)

Drug-drug interactions: it is not only CYP450's which matter
por: Back, David J
Publicado: (2010)

Structural and catalytic properties of the peroxygenase P450 enzyme CYP152K6 from Bacillus methanolicus
por: Girvan, Hazel M., et al.
Publicado: (2018)

In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9
por: Nembri, Serena, et al.
Publicado: (2016)

The cytochrome P450 (CYP) gene superfamily in Daphnia pulex
por: Baldwin, William S, et al.
Publicado: (2009)

Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
por: Pedersen, Kata W., et al.
Publicado: (2021)

The Biological Fate of a Novel Anticancer Drug Candidate TNBG-5602: Metabolic Profile, Interaction with CYP450, and Pharmacokinetics in Rats
por: Li, Rui, et al.
Publicado: (2022)

A clinical drug–drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib
por: Malhi, Vikram, et al.
Publicado: (2016)

Drugs impact on CYP-450 enzyme family: A pharmacogenetical study of response variation
por: Kalra, Kapil, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_k2v9hcmk2hb7561iisl1s3e22f